A feasibility study of image-guided hypofractionated conformal arc therapy for inoperable patients with localized non-small cell lung cancer.

Authors :: Bral S
Van Parijs H
Soete G
Linthout N
Van Moorter L
Verellen D
Storme G
Source :: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology [Radiother Oncol] 2007 Sep; Vol. 84 (3), pp. 252-6. Date of Electronic Publication: 2007 Aug 27.
Publication Year :: 2007
Abstract: We treated 36 cases of stage I/II non-small cell lung cancer in inoperable patients. Treatments were planned to a total isocenter dose of 60Gy (8x7.5Gy) based on a dynamic field shaping arc, employing one arc to span as much area as possible and if needed additional weighted segments. The 2 year infield progression free probability is 65%. Disease-specific survival is 75% at 2 years. No patients experienced grade 3-4 toxicity.

Subjects :: Aged
Aged, 80 and over
Carcinoma, Non-Small-Cell Lung mortality
Feasibility Studies
Female
Humans
Male
Middle Aged
Treatment Outcome
Carcinoma, Non-Small-Cell Lung radiotherapy
Lung Neoplasms radiotherapy
Radiotherapy, Conformal methods

Language :: English
ISSN :: 0167-8140
Volume :: 84
Issue :: 3
Database :: MEDLINE
Journal :: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology
Publication Type :: Academic Journal
Accession number :: 17720266
Full Text :: https://doi.org/10.1016/j.radonc.2007.07.010

Full Text Access

Tools